SHELTERPharmaceuticals
Shelter Pharma Ltd — Cash Flow Statement
₹26.83
-1.86%
Shelter Pharma Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 2.83 Cr | -2.81 Cr | -0.97 Cr | -0.09 Cr | — |
| Issuance Of Capital Stock | 0.00 | 10.91 Cr | 0.00 | 0.00 | — |
| Capital Expenditure | -2.65 Cr | -0.85 Cr | -41000.00 | -0.60 Cr | — |
| End Cash Position | 3.42 Cr | 5.04 Cr | 0.43 Cr | 0.10 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -1000.00 | 0.11 Cr | 0.90 Cr | -1000.00 | — |
| Beginning Cash Position | 5.04 Cr | 0.43 Cr | 0.10 Cr | 0.37 Cr | — |
| Changes In Cash | -1.62 Cr | 4.50 Cr | -0.57 Cr | -0.27 Cr | — |
| Financing Cash Flow | 0.03 Cr | 11.01 Cr | 0.28 Cr | 0.06 Cr | — |
| Net Other Financing Charges | 1000.00 | — | — | — | — |
| Cash Dividends Paid | -0.38 Cr | — | — | — | — |
| Net Common Stock Issuance | 0.00 | 10.91 Cr | -0.20 Cr | 0.00 | — |
| Common Stock Issuance | 0.00 | 10.91 Cr | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | 0.36 Cr | 0.09 Cr | 0.48 Cr | 0.06 Cr | — |
| Net Long Term Debt Issuance | 0.36 Cr | 0.09 Cr | 0.48 Cr | 0.06 Cr | — |
| Investing Cash Flow | -7.13 Cr | -4.54 Cr | 0.11 Cr | -0.85 Cr | — |
| Interest Received Cfi | 55000.00 | 13000.00 | 24000.00 | 1000.00 | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | -5000.00 | — |
| Purchase Of Investment | 0.00 | 0.00 | 0.00 | -5000.00 | — |
| Net PPE Purchase And Sale | -2.65 Cr | -0.85 Cr | -41000.00 | -0.60 Cr | — |
| Purchase Of PPE | -2.65 Cr | -0.85 Cr | -41000.00 | -0.60 Cr | — |
| Operating Cash Flow | 5.48 Cr | -1.96 Cr | -0.96 Cr | 0.52 Cr | — |
| Taxes Refund Paid | -2.44 Cr | -1.56 Cr | 0.00 | 0.00 | — |
| Change In Working Capital | -2.03 Cr | -9.26 Cr | -8.19 Cr | -2.04 Cr | — |
| Change In Other Current Liabilities | 0.11 Cr | -3.86 Cr | 1.13 Cr | 0.20 Cr | — |
| Change In Other Current Assets | 0.23 Cr | 0.12 Cr | 0.32 Cr | 0.28 Cr | — |
| Change In Payable | 0.54 Cr | 0.25 Cr | 0.14 Cr | 0.01 Cr | — |
| Change In Inventory | -2.97 Cr | -2.07 Cr | -2.29 Cr | -1.66 Cr | — |
| Change In Receivables | -2.45 Cr | -4.55 Cr | -6.59 Cr | -0.85 Cr | — |
| Other Non Cash Items | -55000.00 | -39000.00 | -24000.00 | -0.06 Cr | — |
| Deferred Tax | 0.00 | 0.04 Cr | 0.00 | 0.00 | — |
| Depreciation And Amortization | 0.27 Cr | 0.25 Cr | 0.16 Cr | 0.17 Cr | — |
| Depreciation | 0.27 Cr | 0.25 Cr | 0.16 Cr | 0.17 Cr | — |
| Net Income From Continuing Operations | 9.68 Cr | 8.28 Cr | 7.05 Cr | 2.51 Cr | — |
| Repurchase Of Capital Stock | — | — | -0.20 Cr | — | — |
| Issuance Of Debt | — | — | 0.42 Cr | 0.06 Cr | 0.00 |
| Common Stock Payments | — | — | -0.20 Cr | — | — |
| Long Term Debt Issuance | — | — | 0.42 Cr | 0.06 Cr | 0.00 |
| Net Other Investing Changes | — | — | -1000.00 | — | — |
| Sale Of Investment | — | — | 0.00 | — | 0.00 |
| Provisionand Write Offof Assets | — | — | 0.07 Cr | 0.00 | 0.00 |
| Pension And Employee Benefit Expense | — | — | 0.01 Cr | -0.07 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Shelter Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.